4.7 Article

Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125:: Immunological response and survival (Phase Ib/II)

Rate this paper

The primary rating indicates the level of overall quality for the paper. Secondary ratings independently reflect strengths or weaknesses of the paper.

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now